Library Item - Page 32 of 792 Posts on Medivizor
Navigation Menu

Library Item Posts on Medivizor

Do patients with diabetes have a different antibody response to COVID-19 vaccines compared to healthy individuals?

Do patients with diabetes have a different antibody response to COVID-19 vaccines compared to healthy individuals?

Posted by on Mar 20, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the antibody response and side effects associated with COVID-19 vaccines administration in patients with type 1 (T1D) and type 2 diabetes (T2D), people without diabetes. The data showed similar immune responses in patients with and without diabetes after the second COVID-19 vaccine,...

Read More

Can high-frequency spinal cord stimulation provide relief to patients with painful diabetic nerve disease?

Can high-frequency spinal cord stimulation provide relief to patients with painful diabetic nerve disease?

Posted by on Mar 20, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the long-term impact of 10-kHz spinal cord stimulation (SCS) in patients with painful diabetic neuropathy (PDN; nerve disease) and refractory symptoms. The data supported the use of 10-kHz SCS for important, durable pain relief over 12 months in these patients. Some background Diabetic sensorimotor peripheral...

Read More

Investigating the effectiveness and safety of combining low-intensity extracorporeal shock wave therapy with tadalafil and L-arginine for the treatment of erectile dysfunction.

Investigating the effectiveness and safety of combining low-intensity extracorporeal shock wave therapy with tadalafil and L-arginine for the treatment of erectile dysfunction.

Posted by on Mar 20, 2022 in Erectile dysfunction | 0 comments

In a nutshell This study investigated the effectiveness and safety of combining low-intensity extracorporeal shock wave therapy (Li-ESWT) with tadalafil (Cialis) and L-arginine for the treatment of patients with mild and moderate erectile dysfunction (ED). The data showed that daily therapy with tadalafil and L-arginine increased the...

Read More

Evaluating the safety and effectiveness of blinatumomab for the treatment of children with relapsed or refractory B-cell acute lymphoblastic leukemia.

Evaluating the safety and effectiveness of blinatumomab for the treatment of children with relapsed or refractory B-cell acute lymphoblastic leukemia.

Posted by on Mar 20, 2022 in Leukemia | 0 comments

In a nutshell This study evaluated the safety and effectiveness of blinatumomab (Blincyto) for the treatment of children with relapsed or refractory (r/r) B-cell acute lymphoblastic leukemia (B-ALL). The data showed that blinatumomab was safe and effective for these patients. Some background B-ALL is a type of cancer in which the body makes...

Read More

Evaluating the risk factors associated with radiation skin irritation after radiotherapy in patients with breast cancer

Evaluating the risk factors associated with radiation skin irritation after radiotherapy in patients with breast cancer

Posted by on Mar 20, 2022 in Breast cancer | 0 comments

In a nutshell This study evaluated the risk factors associated with acute radiation dermatitis (ARD; skin irritation) after radiotherapy (RT) in patients with breast cancer (BC). The data showed that patients with diabetes, smokers, and those with a body mass index (BMI; a measure of body weight in relation to height) of more than 25 kg/m2 had a...

Read More

What is the usefulness of measurable residual disease in patients with acute myeloid leukemia treated with venetoclax and azacitidine?

What is the usefulness of measurable residual disease in patients with acute myeloid leukemia treated with venetoclax and azacitidine?

Posted by on Mar 15, 2022 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the outcomes for acute myeloid leukemia (AML) patients treated with venetoclax (Venclexta) and azacitidine (Vidaza) who achieved complete remission (CR) and minimal measurable residual disease (MRD) after treatment.  This study concluded that patients who achieved both CR and minimal...

Read More

Evaluating quality of life in patients with relapsed or refractory multiple myeloma treated with idecabtagene vicleucel

Evaluating quality of life in patients with relapsed or refractory multiple myeloma treated with idecabtagene vicleucel

Posted by on Mar 15, 2022 in Multiple Myeloma | 0 comments

In a nutshell This study aimed to investigate the effect of idecabtagene vicleucel (ABECMA; ide-cel) treatment on health-related quality of life (HR-QoL) in patients with relapsed or refractory (r/r) multiple myeloma (MM).   This study concluded that this treatment improves HR-QoL for these patients.   Some...

Read More

Evaluating the effectiveness and safety of vagus nerve stimulation for improving arm function after ischemic stroke.

Evaluating the effectiveness and safety of vagus nerve stimulation for improving arm function after ischemic stroke.

Posted by on Feb 27, 2022 in Stroke | 0 comments

In a nutshell This study evaluated the effectiveness and safety of vagus nerve stimulation (VNS) for improving upper limb function in patients after ischemic stroke. The data showed that VNS was safe and improved upper limb function in these patients. Some background An ischemic stroke happens when blood flow through the blood vessels that supply...

Read More

Evaluating the effectiveness and safety of ropinirole for the treatment of Parkinson’s disease.

Evaluating the effectiveness and safety of ropinirole for the treatment of Parkinson’s disease.

Posted by on Feb 27, 2022 in Parkinson's Disease | 0 comments

In a nutshell This study evaluated the effectiveness and safety of ropinirole (Requip) for the treatment of patients with Parkinson’s disease (PD). The data showed that ropinirole was effective in improving motor function and daily living of patients with PD but was associated with an increase in side effects. Some background Parkinson's...

Read More

Evaluating the effectiveness of immunotherapy in advanced lung cancer with and without brain metastases.

Evaluating the effectiveness of immunotherapy in advanced lung cancer with and without brain metastases.

Posted by on Feb 27, 2022 in Lung cancer | 0 comments

In a nutshell This study evaluated the effectiveness of immunotherapy in advanced lung cancer (LC) patients with and without brain metastases (BMs). The data showed that immunotherapy significantly improved overall survival in LC patients with and without BMs. Some background In 20-40% of patients with advanced LC, the cancer spreads from the lung to...

Read More

Evaluating the effectiveness of trilaciclib given before chemotherapy in patients with metastatic triple-negative breast cancer.

Evaluating the effectiveness of trilaciclib given before chemotherapy in patients with metastatic triple-negative breast cancer.

Posted by on Feb 25, 2022 in Breast cancer | 0 comments

In a nutshell This study evaluated the effectiveness of trilaciclib (Cosela) given before gemcitabine (Gemzar) plus capecitabine (Xeloda) (GC) chemotherapy regimen in patients with metastatic triple-negative breast cancer (mTNBC). The data showed that trilaciclib given before GC chemotherapy regimen was effective and significantly improved overall...

Read More

Factors affecting long-term dutasteride add-on treatment to alpha-adrenergic antagonist for patients with BPH

Factors affecting long-term dutasteride add-on treatment to alpha-adrenergic antagonist for patients with BPH

Posted by on Feb 20, 2022 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study identified clinical risk factors that resulted in the failure of dutasteride (Avodart) add-on treatment to alpha-adrenergic antagonists for patients with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). The authors concluded that an intravesical prostatic protrusion (IPP; the enlargement of the...

Read More